Skip to main content

Table 2 Characteristics and outcomes of retrieved trials for the outcome “Acute cardiac injury” and “Acute myocardial infarction”

From: Cardiac complications in patients with COVID-19: a systematic review

Acute cardiac injuryΔ

Authors

Age (years) all patients

Age (years) treatment group

Age (years) control group

Sex M/F+

Cardiological comorbidities (n° pts)

Other comorbidities (n° pts)

COVID-19 severity

Acute cardiac injury (n° pts or cases-controls)

Troponin T or I value—BNP or NT-proBNP valueπ

LVEDV – EF (n° pts or cases-controls)π

Other no cardiac complications (n° pts)

Outcome (n° pts or cases-controls)

Bangalore et al. [13]

63 (54–73)§

60 (56–73)§

66 (54–73)§

15/3

Hypertension (11)

Diabetes (6)

Dyslipidemia (7)

Smoking (1)

Coronary heart disease (3)

Chronic kidney disease (1)

NA

10

TnI 13.5 (4.8–41) ng/ml§

TnT 0.02 ng/ml§

Not reported (2)

NA

Death (4-9)

Cao et al. [15]

54 (37–67)§

66 (54–76)§

31 (35–62)§

53/49

Hypertension (28)

Diabetes (11)

Cardiovascular disease (5)

Cerebrovascular diseases (6)

Respiratory diseases (10)

Malignancy (4)

Chronic kidney disease (4)

Chronic liver disease (2)

Patients subjected to mechanical ventilation, ECMO, and CRRT

6–9

NA

NA

Shock (10)

ARDS (20)

Acute infections (17)

Acute kidney damage (20)

Chronic kidney damage (34)

ECMO (3)

Mechanical ventilation (7)

CRRT (4)

Death (6-11)

Discharge (12-73)

Chen et al. [16]

57.6 (44.9–70.3)§

56.1 ± 13.5°

61.7 ± 9.6°

36/18

Hypertension (16)

Diabetes (25)

Coronary heart disease (6)

NA

Severe condition if:

Respiratory distress, RR > 30 acts/min or

SpO2 < 93% rest or P/F < 300

Critical condition if:

Mechanical ventilation or shock or failure of other organs that requires intensive monitoring and treatment

0–3

TnI 0.29 ± 0.68 ng/ml°

NT-proBNP 1582 ± 2374 pg/ml°

NA

AKI (18)

NA

Chen et al. [17]

62 (44–70)§

68 (62–77)§

51 (37–66)§

171/103

Hypertension (93)

Smoke (12)

Diabetes (47)

Cardiovascular disease (23)

Chronic heart failure (1)

Cerebrovascular disease (4)

Chronic lung disease (18)

Malignancy (7)

Chronic kidney disease (4)

Autoimmune disease (2)

According to the China Guidance for Corona Virus Disease 2019 (6th edition)

72–18

NA

NA

ARDS (192)

Sepsis (179)

AKI (29)

DIC (21)

Shock (46)

Acute liver injury (13)

Mechanical ventilation (119)

CRRT (3)

ECMO (1)

Death (113)

Recovered (161)

Du et al. [22]

65.8 ± 14.2°

NA

NA

62/23

Hypertension (32)

Diabetes (19)

Coronary heart disease (10)

Cerebrovascular diseases (7)

Chronic liver disease (5)

Chronic kidney disease (3)

COPD (2)

Malignancy (6)

On the recommendations by the National Institute for Viral Disease Control and Prevention, China (fifth edition)

38

NA

NA

Respiratory failure (80)

Shock (69)

ARDS (63)

Acute liver injury (38)

Sepsis (28)

Death (51)

Guo et al. [25]

58.5 (14.66)°

53.53 (13.22)°

34 (65.4)°

91/96

Smoking (18)

Hypertension (61)

Coronary heart disease (21)

Cardiomyopathy (8)

Diabetes (28)

COPD (4)

Malignancy (13)

Chronic kidney disease (6)

NA

135–52

NT-proBNP 268.4 (75.3–689.1)§

NA

ARDS (46)

Acute coagulopathy (42)

Liver injury (19)

Kidney injury (18)

Mechanical ventilation (45)

Death (12-31)

Huang et al. [27]

49 (41–58)§

49 (41–61)§

49 (41–57.5)§

30/11

Smoke (3)

Hypertension (6)

Diabetes (8)

Cardiovascular disease (6)

COPD (1)

Malignancy (1)

Chronic liver disease (1)

Patients developed ARDS, requiring ICU admission and oxygen therapy

4-1

TnI > 28 pg/ml

NA

Pneumonia (41)

ARDS (12)

AKI (3)

Secondary infection (4)

Shock (3)

CRRT (3)

NIV (10)

Invasive mechanical ventilation (2)

ECMO (2)

Death (6)

Discharge (28)

Ruan et al. [39]

NA

67 (15–81)§

50 (44–81)§

102/48

Hypertension (52)

Cardiovascular disease (13)

Diabetes (25)

Cerebrovascular disease (12)

COPD (3)

Chronic kidney disease (2)

Malignancy (3)

Chronic liver disease (4)

NA

27

NA

NA

Respiratory failure (71)

ARDS (62)

AKI (23)

Infection (12)

Mechanical ventilation (25)

ECMO (7)

CRRT (5)

Death (68)

Discharged (82)

Shao et al. [42]

73.5 (29–66)§

NA

NA

13/5

Hypertension (10)

Diabetes (4)

Cerebrovascular disease (5)

Renal disease (3)

Malignancy (2)

COPD (2)

HIV (1)

Autoimmune disease (1)

Based on The National Health Commission of China Guidelines (7th edition)

10

NA

NA

ARDS (17)

Invasive mechanical ventilation (11)

CRRT (7)

AKI (7)

Shock (6)

ECMO (1)

Gastrointestinal bleeding (1)

Perforation of the intestine (1)

Co-infection (5)

Death (10)

Kunal et al. [32].

51.2 ± 17.7°

60.9 ± 15.1°

47.9 ± 17.4°

70/38

Hypertension (41)

Diabetes (35)

Cardiovascular disease (14)

Dyslipidemia (6)

Heart failure (1)

COPD (6)

NA

28–80

TnT 0.66 ± 1.28° mcg/L

NA

Sepsis (25)

ARDS (12)

AKI (8)

Diabetic ketoacidosis (3)

Intracranial hemorrhage (1)

Death (16-14)

Shi et al. [43]

64 (21–95)§

74 (34–95)§

60 (21–90)§

205/211

Hypertension (127)

Diabetes (60)

Coronary heart disease (44)

Cerebrovascular disease (22)

Chronic heart failure (17)

chronic kidney disease (14)

COPD (12)

Malignancy (9)

Hepatitis B infection (4)

NA

82–334

Hs TnI 0,19 (0.08–1.12) mcg/L§

NT-proBNP 1689 (698–3327) pg/ml§

NA

Noninvasive ventilation (51)

Invasive mechanical ventilation (32)

CRRT (2)

ARDS (97)

AKI (8)

Death (42-15)

Discharge (2-38)

Recovered (38-281)

Shi et al. [44]

63 (50–72)§

73 (66–80)§

57 (43–70)§

322/349

Hypertension (199)

Diabetes (97)

Coronary heart disease (60)

Chronic heart failure (22)

Cerebrovascular disease (22)

Atrial fibrillation (7)

Chronic renal disease (28)

COPD (23)

Cancer (23)

Severe and critical diseases are defined by the presence of any of RR > 30 acts/min; oxygen saturation ≤ 93%; PaO2/FiO2 ratio < 300 mmHg; respiratory failure requiring mechanical ventilation; shock; respiratory failure with other organ failure requiring ICU management

106

TnI 0.159 (0.075–0.695) ng/ml§

NT-proBNP 1346 (474–3018) pg/ml§

NA

Invasive mechanical ventilation (36)

ECMO (2)

CRRT (4)

Death (62)

Survivors (609)

Szekely et al. [47]

66.1 ± 17.3°

65.9 ± 20°

69.8 ± 16°

63/37

Hypertension (57)

Ischemic heart disease (16)

Congestive heart failure (7)

Cerebrovascular disease (11)

Atrial fibrillation (715)

Chronic renal disease (10)

Diabetes (29)

Obesity (29)

Asthma (7)

Malignancy (5)

Acuity score

Troponin level above the 99th percentile was reported in 20% of the patients

Tn I 11 (5–39) ng/L§

BNP 43 (18–144) pg/L§

EF 58.2 ± 4°

NA

NA

Tavazzi et al. [48]

69+

NA

NA

1/0

NA

NA

NA

1

NA

LVEDV 56 mm+

EF 34%+

Bilateral interstitial pneumonia (1)

Mechanical ventilation (1)

IABP (1)

ECMO (1)

Septic shock (1)

Death (1)

Wan et al. [50]

47 (36–55)§

44 (33–49)§

56 (52–73)§

72/63

Current smoking (9)

Diabetes (12)

Hypertension (13)

Malignancy (4)

Pulmonary disease (1)

Chronic liver disease (2)

The mild group had mild symptoms and no pneumonia;

the normal group had fever, respiratory symptoms, and pneumonia;

the severe group had respiratory distress, RR ≥ 3acts/min at rest, mean oxygen saturation ≤ 93%, and P/F ≤ 300 mmHg;

the critical group had respiratory failure with mechanical ventilation, shock, and other failures, requiring ICU treatment

8-2

NA

NA

ARDS (21)

AKI (5)

Secondary infection (7)

Shock (1)

CRRT (5)

Invasive mechanical ventilation (1)

Death (0-1)

Discharge (10-5)

Hospitalization (85-35)

Xiong et al. [52]

58.5 (47–69)§

56 (37–64)§

64 (53–76)§

80/63

Diabetes (19)

Hypertension (45)

Coronary Heart Disease (17)

Cardiovascular disease (8)

COPD (1)

Malignancy (4)

Chronic liver disease (2)

Moderate cases: mild respiratory symptoms with pneumonia

Severe cases: dyspnea, RR ≥ 30/min, blood oxygen saturation ≤ 93%, PaO2/FiO2 ratio ≤ 300 mmHg, and/or pulmonary inflammation progressing > 50% within 24 to 48 h.

Critical cases: respiratory failure, shock, and/or multiple organ dysfunction

4–19

TnT > 0.02 ng/ml+

NT-proBNP 71.5 (27–363.5)§ pg/ml

NA

Shock (16)

ARDS (20)

Liver dysfunction (15)

AKI (3)

Invasive mechanical ventilation (10)

ECMO (3)

Discharge (61-48)

Death (0-7)

Yang et al. [53]

59.7 (13,3)°

51,9 (12.9)°

64.6 (11.2)°

14/6

Chronic cardiac disease (5)

Cerebrovascular disease (7)

Diabetes (9)

Smoke (2)

Chronic pulmonary disease (4)

Malignancy (2)

Admission to ICU requiring mechanical ventilation or FiO2 ≥ 60%

3–9

TnI > 28 pg/ml

NA

ARDS (35)

AKI (15)

Liver dysfunction (15)

Hospital-acquired pneumonia (6)

Invasive mechanical ventilation (22)

ECMO (6)

CRRT (9)

Death (32)

Discharge (20)

Yu et al. [54]

64 (57–70)§

NA

NA

139/87

Hypertension (96)

Coronary heart disease (22)

Myocardial infarction (6)

Congestive heart failure (4)

Diabetes (47)

Cerebrovascular disease (15)

Chronic pulmonary disease (15)

Chronic hepatopathy (3)

Chronic nephrosis (8)

Malignancy (10)

RR > 40 acts/min, PaO2 < 60 mmHg, SpO2 < 90% with oxygen support of ≥7 L/min for at least 30 min, PaCO2 > 50 mmHg, hemodynamic instability, use of vasopressors, GCS ≤ 12, CRRT

61

TnI > 0.3 ng/mL

NA

ARDS (161)

Shock (36)

AKI (57)

Bacterial or fungal infection (49)

Gastrointestinal hemorrhage (7)

Death (9)

Discharge from ICU (13)

ICU (204)

Zhang et al. [56]

55 (39–66.5)§

62 (52–74)§

51 (36–64.3)§

108/113

Hypertension (54)

Diabetes (22)

Cardiovascular disease (22)

Cerebrovascular disease (15)

COPD (6)

Chronic kidney disease (6)

Chronic liver disease (7)

Malignancy (9)

Admission in ICU

16-1

NA

NA

ARDS (48)

Shock (15)

AKI (10)

CRRT (5)

Mechanical ventilation (16)

ECMO (10)

Death (12-0)

Discharge (7-35)

Hospitalization (36-131)

Zhao et al. [57]

46§

50.5§

42§

49/42

Hypotension (18)

Diabetes (3)

COPD (1)

Autoimmune disease (1)

Kidney disease (1)

Malignancy (3)

NA

8–6

NA

NA

Pneumonia (91)

Digestive tract disease (14)

Liver disease (18)

Renal disease (5)

Coagulopathy (19)

Mechanical ventilation (5)

CRRT (3)

Death (2-0)

Discharge (14-2)

Hospitalization (26-49)

Zhou et al. [58]

56 (46–67)§

69 (63–76)§

52 (45–58)§

119/72

Hypertension (58)

Diabetes (36)

Coronary heart disease (15)

COPD (6)

Carcinoma (2)

Chronic kidney disease (2)

NA

32-1

TnI > 28 pg/ml

NA

Sepsis (112)

Respiratory failure (103)

ARDS (59)

Invasive mechanical ventilation (32)

Coagulopathy (37)

Septic shock (38)

Acute kidney injury (28)

ECMO (3)

CRRT (10)

Secondary infection (28)

Death (54)

Discharged (137)

Acute myocardial infarction

Authors

Age (years) all patients

Age (years) treatment group

Age (years) control group

Sex M/F+

Cardiological comorbidities (n° pts)

Other comorbidities (n° pts)

COVID-19 severity

EKG (n° pts)

Coronarography/PCI (n° pts or cases-controls)

Troponin T or I value -BNP or NT-proBNP valueπ

Other no cardiac complications (n° pts)

Outcome (n° pts or cases-controls)

Bangalore et al. [13]

63 (54–73)§

60 (56-73)§

66 (54-73)§

15/3

Hypertension (11)

Diabetes (6)

Dyslipidemia (7)

Smoking (1)

Coronary heart disease (3)

Chronic kidney disease (1)

NA

STEMI (8)

6/5–3/0

TnT 6.3 (5.3–7.2) ng/ml§

TnI 91 (65.5–345) ng/ml§

NA

Death (4-9)

Barton et al .[14]

77/42+

77

42

2/0

Hypertension (2)

Obesity (2)

Coronary heart disease (2)

Dilated cardiopathy (1)

Oncocytoma (1)

Prostate hyperplasia (1)

Muscular dystrophy (1)

Cirrhosis (1)

Nephrosclerosis (1)

NA

NA

NA

NA

ARDS (1)

Liver failure (1)

Pneumonia ab ingestis (1)

Death (2)

Dominguez-Erquicia et al. [20]

64+

NA

NA

1/0

NA

NA

NA

STEMI (1)

1/1

NA

Bilateral pneumonia (1)

Discharge (1)

Dweck et al. [24]

62 (52–71)§

64 (53–73)§

60 (51–69)§

844/365

Hypertension (445)

Diabetes (233)

Ischemic heart disease (167)

Heart failure (113)

Valvular disease (80)

NA

Patients in critical care setting (ICU, coronary care unit, emergency room, cardiac catheter laboratory)

Not reported (27)

STEMI (8)

NA

NA

NA

NA

Kim HN et al. [30]

60+

NA

NA

1/0

Hypertension (1)

Diabetes (1)

Dyslipidemia (1)

NA

Mechanical oxygenation supports

STEMI (1)

1/1

TnI 46.1 ng/ml+

NT-proBNP 1971.5 pg/ml+

Bilateral infiltration (1)

Mechanical ventilation (1)

CRRT (1)

ECMO (1)

Death (1)

Kunal et al. [32]

51.2 ± 17.7°

60.9 ± 15.1°

47.9 ± 17.4°

70/38

Hypertension (41)

Diabetes (35)

Cardiovascular disease (14)

Dyslipidemia (6)

Heart failure (1)

COPD (6)

NA

STEMI (3)

NSTEMI (1)

NA

NA

Sepsis (25)

ARDS (12)

AKI (8)

Diabetic ketoacidosis (3)

Intracranial hemorrhage (1)

Death (16-14)

Stefanini et al. [46]

68 ± 11°

NA

NA

20/8

Hypertension (20)

Diabetes (9)

Previous myocardial infarction (3)

Chronic kidney disease (8)

NA

STEMI (25)

New LBBB (3)

28/17

NA

NA

Death (11)

Discharge (16)

ICU (1)

  1. Data are presented as real number+, percentage^, mean ± SD°, or median and (IQR)§
  2. M male, F female, pts patients, TnT troponin T, TnI troponin I, BNP brain natriuretic peptide, NT-proBNP N-terminal pro-brain natriuretic peptide, EF ejection fraction, LVEDV left ventricular end-diastolic volume, NA not applicable, ECMO extra-corporeal membrane oxygenation, CRRT continuous renal replacement therapy, ARDS acute respiratory distress syndrome, RR respiratory rate, SpO2 peripheral oxygen saturation, P/F PaO2/FiO2, PaO2 partial pressure of oxygen in arterial blood, FiO2 oxygen inspired fraction, PaCO2 pressure of arterial carbon dioxide, AKI acute kidney injury, COPD chronic obstructive pulmonary disease, ICU intensive care unit, NIV noninvasive ventilation, HIV human immunodeficiency virus, IABP intra-aortic balloon pump, PCI percutaneous coronary intervention, EKG electrocardiogram, STEMI ST-elevation myocardial infarction, DIC disseminated intravascular coagulation, LBBB left bundle branch block
  3. ΔAs reported in studies, not better specified; πreferred to patient with complication in exam